Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases.
Active drug safety surveillance may be enhanced by analysis of multiple observational healthcare databases, including administrative claims and electronic health records. The objective of this study was to develop and evaluate a common data model (CDM) enabling rapid, comparable, systematic analyses across disparate observational data sources to identify and evaluate the effects of medicines.
Author(s): Reisinger, Stephanie J, Ryan, Patrick B, O'Hara, Donald J, Powell, Gregory E, Painter, Jeffery L, Pattishall, Edward N, Morris, Jonathan A
DOI: 10.1136/jamia.2009.002477